These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cytochrome P450 pharmacogenetics and cancer. Rodriguez-Antona C, Ingelman-Sundberg M. Oncogene; 2006 Mar 13; 25(11):1679-91. PubMed ID: 16550168 [Abstract] [Full Text] [Related]
4. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C. Pharmacol Ther; 2007 Dec 13; 116(3):496-526. PubMed ID: 18001838 [Abstract] [Full Text] [Related]
5. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment. Mathijssen RH, van Schaik RH. Eur J Cancer; 2006 Jan 13; 42(2):141-8. PubMed ID: 16325399 [Abstract] [Full Text] [Related]
6. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes. van Schaik RH. Invest New Drugs; 2005 Dec 13; 23(6):513-22. PubMed ID: 16267627 [Abstract] [Full Text] [Related]
7. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Ingelman-Sundberg M. Trends Pharmacol Sci; 2004 Apr 13; 25(4):193-200. PubMed ID: 15063083 [Abstract] [Full Text] [Related]
9. Pharmacogenetics and the concept of individualized medicine. Shastry BS. Pharmacogenomics J; 2006 Apr 13; 6(1):16-21. PubMed ID: 16302022 [Abstract] [Full Text] [Related]
10. Pharmacogenetics in HIV therapy. Rodríguez-Nóvoa S, Barreiro P, Jiménez-Nacher I, Rendón A, Soriano V. AIDS Rev; 2005 Apr 13; 7(2):103-12. PubMed ID: 16092504 [Abstract] [Full Text] [Related]
11. Pharmacogenetics for individualized cancer chemotherapy. Efferth T, Volm M. Pharmacol Ther; 2005 Aug 13; 107(2):155-76. PubMed ID: 15890408 [Abstract] [Full Text] [Related]
12. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Zhou SF, Liu JP, Chowbay B. Drug Metab Rev; 2009 Aug 13; 41(2):89-295. PubMed ID: 19514967 [Abstract] [Full Text] [Related]
13. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs]. Quiñones S L, Rosero P M, Roco A A, Moreno T I, Sasso A J, Varela F N, Cáceres L D, Saavedra S I. Rev Med Chil; 2008 Oct 13; 136(10):1327-35. PubMed ID: 19194632 [Abstract] [Full Text] [Related]
14. [Pharmacogenomics: the quest for individualized therapy]. López-López M, Guerrero-Camacho JL, Familiar-López IM, Jung-Cook H, Corona-Vázquez T, Alonso-Vilatela ME. Rev Neurol; 2008 Oct 13; 39(11):1063-71. PubMed ID: 15597270 [Abstract] [Full Text] [Related]
15. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness]. Ozawa S. Rinsho Byori; 2003 Feb 13; 51(2):168-73. PubMed ID: 12690635 [Abstract] [Full Text] [Related]
16. Cancer pharmacogenomics: achievements in basic research. Nakajima M, Yokoi T. Int J Clin Oncol; 2005 Feb 13; 10(1):14-9. PubMed ID: 15729595 [Abstract] [Full Text] [Related]
17. [Pharmacogenetics of anticancer drugs]. de Chaisemartin L, Loriot MA. Pathol Biol (Paris); 2005 Mar 13; 53(2):116-24. PubMed ID: 15708657 [Abstract] [Full Text] [Related]
18. [Pharmacogenetics: towards personalized medicine]. Gurwitz D, Rehavi M. Harefuah; 2005 Oct 13; 144(10):711-6, 750. PubMed ID: 16281764 [Abstract] [Full Text] [Related]
20. Genetic factors in drug metabolism. Belle DJ, Singh H. Am Fam Physician; 2008 Jun 01; 77(11):1553-60. PubMed ID: 18581835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]